Melphalan With BBBD in Treating Patients With Brain Malignancies

Clinical trial NCT00253721 · TERMINATED

Trial details

NCT number: NCT00253721
Sponsor: OHSU Knight Cancer Institute
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Lymphoma Metastatic Cancer

Start date: 1998-05-01
Primary completion: 2015-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.